UNH UnitedHealth Group Incorporated Common Stock (DE)
$387,33
Prix · Aoû 21, 2026
Données fondamentales au Aoû 10, 2026
Fourchette 52 semaines
$256–$462
64% of range
Note des analystes
BUY
34 analysts
Objectif de cours
$475
+23% upside
P/E (TTM)
29.3
ROE
12.0%
Marge nette
2.7%
À propos de UnitedHealth Group Incorporated Common Stock (DE) Présentation de l'entreprise depuis Wikipedia
UnitedHealth Group Inc. est une compagnie d'assurance américaine à but lucratif spécialisée dans la santé fondée en 1977 par Richard T. Burke.
Lire la suite
UnitedHealth Group Inc. est une compagnie d'assurance américaine à but lucratif spécialisée dans la santé fondée en 1977 par Richard T. Burke.
En 2018, elle est la plus importante entreprise au monde dans le domaine de la santé, avec un chiffre d'affaires dépassant 226,2 milliards de dollars et près de 115 millions de clients.
Le groupe United Health est coté en bourse et actif presque exclusivement aux États-Unis. Son siège est basé à Minnetonka, dans le Minnesota.
Histoire
Histoire récente
En 2012, UnitedHealth rachète l'entreprise brésilienne de cliniques Amil Participações pour 4,9 milliards de $.
En septembre 2014, UnitedHealth acquiert MedSynergies, une entreprise de management de médecins, pour un montant inconnu.
En mars 2015, UnitedHealth acquiert pour 12,8 milliards de dollars Catamaran, une entreprise de gestion de dépenses de santé, appelée pharmacy benefit management, entreprise créée en 2012 par la fusion de SXC Health Solutions et de PBM Catalyst Health Solutions.
En janvier 2017, UnitedHealth annonce l'acquisition de Surgical Care Affiliates, entreprise spécialisée dans les centres de chirurgie, pour 2,3 milliards de dollars. En décembre 2017, UnitedHealth annonce l'acquisition des activités de soins d'urgences de DaVita pour 4,9 milliards de dollars. Le même mois, UnitedHealth annonce l'acquisition de Banmedica, une entreprise chilienne d'assurance maladie, pour 2,8 milliards de dollars.
En juin 2019, UnitedHealth annonce l'acquisition de Equian, pour 3,2 milliards de dollars. En décembre 2019, UnitedHealth annonce l'acquisition de Diplomat Pharmacy, une chaîne de pharmacie américaine, pour 300 millions de dollars.
En janvier 2021, UnitedHealth annonce l'acquisition de Change Healthcare, entreprise spécialisée dans le paiement des actes médicaux, pour 7,84 milliards de dollars. En février 2022, le ministère de la justice américain annonce son opposition ferme à cette acquisition et l'arrêt de cette opération.
En mars 2022, UnitedHealth annonce l'acquisition de LHC Group, spécialisée dans les services à la personne, pour 5,4 milliards de dollars.
En février 2024, Change Healthcare est touchée par une cyberattaque sur son système informatique, entrainant d'importants retards dans les prescriptions des patients. Afin d'éviter que les données extorquées par le groupe de hackers BlackCat ne soient publiées sur le darknet, Change Healthcare reconnaît avoir payé une rançon de 22 millions de dollars, ce qui n'empêche pas les pirates de faire fuiter les données extorquées sur internet. Change Healthcare évalue la perte depuis l'attaque par rançongiciel à 870 millions de dollars.
Selon ValuePenguin, un groupe d'analystes, UnitedHealthcare refuse environ un tiers des demandes de prise en charge médicale à ses assurés, le taux le plus élevé de toutes les compagnies d'assurance et le double de la moyenne du secteur.
Le 4 décembre 2024, Brian Thompson, PDG d'UnitedHealth, est assassiné devant l'hôtel Hilton de Midtown à New York. Dans les jours qui ont suivi, les réactions des Américains qui se réjouissaient de cet assassinat soulignent un régime d'assurance santé privé profondément injuste et opaque.
En mai 2025, UnitedHealth Group annonce la démission de son directeur général, Andrew Witty, et la suspension de ses prévisions annuelles en raison de la flambée des coûts médicaux, ce qui entraîne une chute du cours de l'action de près de 38 % sur l'année, à son plus bas niveau en quatre ans. UnitedHealth avait été confronté à plusieurs défis majeurs au cours des douze mois précédents, notamment une cyberattaque contre sa division technologique qui a touché quelque 190 millions de personnes, un rapport d'enquête sur ses pratiques de facturation Medicare et une hausse inattendue des coûts médicaux ayant affecté ses résultats.
Activités
Assurance santé.
Prestations de gestion de régimes d'assurance médicaments, gestion administrative (remboursements, traitement des réclamations des patients).
Prestations de services informatiques.
Données financières
Principaux actionnaires
Au 17 octobre 2021:
== Références ==
Source : Wikipedia, CC BY-SA 4.0 · Voir sur Wikipedia ↗
UNH Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$387.33
Capitalisation Boursière
$351.69B
P/E (TTM)
29.3
BPA (TTM)
$13.23
Revenus (TTM)
$447.57B
Rendement div.
2.3%
ROE
12.0%
Dette/Capitaux propres
0.7
Fourchette 52 semaines
$256 – $462
UNH Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$447.57B
2021-12-31
→
2025-12-31
BPA
$13.23
2021-12-31
→
2025-12-31
Flux de trésorerie libre
$16.07B
2021-12-31
→
2025-12-31
Marges
2.7%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
UNH
Médiane des pairs
P/E (TTM)
29.3
35.0
P/S (TTM)
0.8
0.9
P/B
3.5
3.5
EV / EBITDA
20.9
—
Price / FCF (Cours / FCF)
21.9
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
UNH
Médiane des pairs
Operating Margin (Marge d'exploitation)
4.2%
—
Net Profit Margin (Marge nette)
2.7%
0.89%
ROA
4.0%
3.5%
ROE
12.0%
10.1%
ROIC
9.6%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
UNH
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
0.7
—
Current Ratio (Ratio de liquidité)
0.8
1.6
Quick Ratio (Ratio de liquidité réduite)
0.4
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
UNH
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
11.8%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
11.3%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
11.7%
—
EPS YoY (BPA Année/Année)
-14.7%
—
Net Income YoY (Bénéfice net YoY)
-16.3%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
UNH
Médiane des pairs
Payout Ratio (Ratio de distribution)
65.7%
—
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
Rendement du Dividende
2.3%
Ratio de distribution
65.7%
CAGR des dividendes sur 5 ans
—
| Date ex-dividende | Montant |
|---|---|
| 15 juin 2026 | $2,3200 |
| 9 mars 2026 | $2,2100 |
| 8 décembre 2025 | $2,2100 |
| 15 septembre 2025 | $2,2100 |
| 16 juin 2025 | $2,2100 |
| 10 mars 2025 | $2,1000 |
| 9 décembre 2024 | $2,1000 |
| 16 septembre 2024 | $2,1000 |
| 17 juin 2024 | $2,1000 |
| 8 mars 2024 | $1,8800 |
| 1 décembre 2023 | $1,8800 |
| 8 septembre 2023 | $1,8800 |
| 15 juin 2023 | $1,8800 |
| 10 mars 2023 | $1,6500 |
| 2 décembre 2022 | $1,6500 |
| 9 septembre 2022 | $1,6500 |
| 16 juin 2022 | $1,6500 |
| 11 mars 2022 | $1,4500 |
| 3 décembre 2021 | $1,4500 |
| 10 septembre 2021 | $1,4500 |
UNH Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
34 analystes
- Achat fort 8 23,5%
- Achat 19 55,9%
- Conserver 7 20,6%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
26 analystes · 2026-08-22
Médiane
$490.00
Maintenant
$387.33
Bas
$313.00
Haut
$529.00
Objectif médian
$490.00
+26,5%
Objectif moyen
$475.23
+22,7%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.25%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $6.38 | $4.95 | 1.4% |
| 31 mars 2026 | $7.23 | $6.64 | 0.59% |
| 31 décembre 2025 | $2.11 | $2.12 | -0.01% |
| 30 septembre 2025 | $2.92 | $2.82 | 0.10% |
| 30 juin 2025 | $4.08 | $4.53 | -0.45% |
| 31 mars 2025 | $7.20 | $7.36 | -0.16% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Cost of Revenue | $50.66B | $46.69B | $38.77B | $33.70B | $31.03B | $30.75B | $28.12B | $27.00B | $24.11B | $24.42B | $16.21B | $3.83B | |
| SG&A Expense | $59.59B | $53.01B | $54.63B | $47.78B | $42.58B | $41.70B | $35.19B | $34.07B | $29.56B | $28.40B | $24.31B | $21.26B | |
| Operating Expenses | $428.60B | $367.99B | $339.26B | $295.73B | $263.63B | $234.74B | $222.47B | $208.90B | $185.95B | $171.91B | $146.09B | $120.20B | |
| Operating Income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B | |
| Interest Expense | $4.00B | $3.91B | $3.25B | $2.09B | $1.66B | $1.66B | $1.70B | $1.40B | $1.19B | $1.07B | $790M | $618M | |
| Pretax Income | $14.70B | $20.07B | $29.11B | $26.34B | $22.31B | $20.74B | $17.98B | $15.94B | $14.02B | $11.86B | $10.23B | $9.66B | |
| Income Tax | $1.89B | $4.83B | $5.97B | $5.70B | $4.58B | $4.97B | $3.74B | $3.56B | $3.20B | $4.79B | $4.36B | $4.04B | |
| Net Income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| EPS (Basic) | $13.28 | $15.64 | $24.12 | $21.47 | $18.33 | $16.23 | $14.55 | $12.45 | $10.95 | $7.37 | $6.10 | $5.78 | |
| EPS (Diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 | $10.72 | $7.25 | $6.01 | $5.70 | |
| Shares (Basic) | 908,000,000 | 921,000,000 | 928,000,000 | 937,000,000 | 943,000,000 | 949,000,000 | 951,000,000 | 963,000,000 | 964,000,000 | 952,000,000 | 953,000,000 | 972,000,000 | |
| Shares (Diluted) | 911,000,000 | 929,000,000 | 938,000,000 | 950,000,000 | 956,000,000 | 961,000,000 | 966,000,000 | 983,000,000 | 985,000,000 | 968,000,000 | 967,000,000 | 986,000,000 | |
| EBITDA | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B |
Bilan 26
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.36B | $25.31B | $25.43B | $23.36B | $21.38B | $16.92B | $10.98B | $10.87B | $11.98B | $10.43B | $10.92B | $7.50B | |
| Short-term Investments | $3.76B | $3.80B | $4.20B | $4.55B | $2.53B | $2.86B | $3.26B | $3.46B | $3.51B | $2.85B | $1.99B | $1.74B | |
| Receivables | $23.02B | $22.36B | $21.28B | $17.68B | $14.22B | $12.87B | $11.82B | $11.39B | $9.57B | $8.15B | $6.52B | $4.25B | |
| Inventory | $3.30B | $3.80B | $2.80B | $3.50B | $2.90B | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.75B | $8.21B | $6.08B | $6.62B | $5.32B | $4.46B | $3.85B | $3.09B | $2.66B | $1.85B | $2.41B | $1.05B | |
| Current Assets | $90.58B | $85.78B | $78.44B | $69.07B | $61.76B | $53.72B | $42.63B | $38.69B | $37.08B | $33.88B | $31.64B | $23.56B | |
| PP&E (Net) | $10.76B | $10.55B | $11.45B | $10.13B | $8.97B | $8.63B | $8.70B | $8.46B | $7.01B | $5.90B | $4.86B | $4.42B | |
| Accum. Depreciation | $7.55B | $6.97B | $7.04B | $6.93B | $5.99B | $5.23B | $5.00B | $4.14B | $3.69B | $3.75B | $3.17B | $2.95B | |
| Goodwill | $110.50B | $106.73B | $103.73B | $93.35B | $75.80B | $71.34B | $65.66B | $58.91B | $54.56B | $47.58B | $44.45B | $32.94B | |
| Intangibles | $20.47B | $23.27B | $15.19B | $14.40B | $10.04B | $10.86B | $10.35B | $9.32B | $8.49B | $8.54B | $8.39B | $3.67B | |
| Other Non-current Assets | $23.01B | $19.59B | $17.30B | $15.03B | $12.53B | $11.51B | $9.33B | $4.33B | $3.58B | $3.04B | $3.12B | $2.97B | |
| Total Assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.30B | |
| Accounts Payable | $38.03B | $34.34B | $31.96B | $27.71B | $24.64B | $22.50B | $19.00B | $16.70B | $15.18B | $13.36B | $11.99B | $9.25B | |
| Current Liabilities | $114.90B | $103.77B | $99.05B | $89.24B | $78.29B | $72.42B | $61.78B | $53.21B | $50.46B | $49.25B | $42.90B | $30.62B | |
| Deferred Tax | $2.42B | $3.62B | $3.02B | $2.77B | $3.27B | $3.37B | $2.99B | $2.47B | $2.18B | $2.76B | $3.59B | $2.06B | |
| Other Non-current Liabilities | $18.25B | $15.94B | $14.46B | $12.84B | $11.79B | $12.31B | $10.14B | $5.73B | $5.56B | $4.83B | $1.48B | $1.36B | |
| Total Liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B | $126.75B | $111.73B | $95.99B | $87.04B | $82.62B | $75.79B | $52.54B | |
| Long-term Debt | · | · | · | · | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $31.96B | $17.41B | |
| Total Debt | $72.32B | $72.36B | $58.26B | $54.51B | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $32.09B | $17.41B | |
| Common Stock | $9M | $9M | $9M | $9M | $10M | $10M | $9M | $10M | $10M | $10M | $10M | $10M | |
| Paid-in Capital | $559M | $0 | $0 | · | $0 | $0 | $7M | $0 | $1.70B | $0 | $29M | $0 | |
| Retained Earnings | $95.60B | $96.04B | $95.77B | $86.16B | $77.13B | $69.30B | $61.18B | $55.85B | $48.73B | $40.95B | $37.12B | $33.84B | |
| AOCI | $-2.06B | $-3.39B | $-7.03B | $-8.39B | $-5.38B | $-3.81B | $-3.58B | $-4.16B | $-2.67B | $-2.68B | $-3.33B | $-1.39B | |
| Stockholders' Equity | $100.09B | $98.27B | $94.42B | $81.45B | $75.05B | $68.33B | $60.44B | $54.32B | $49.83B | $38.18B | $33.73B | $32.45B | |
| Liabilities + Equity | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.38B | |
| Shares Outstanding | 906,000,000 | 915,000,000 | 924,000,000 | 934,000,000 | 941,000,000 | 946,000,000 | 948,000,000 | 960,000,000 | 969,000,000 | 952,000,000 | 953,000,000 | 954,000,000 |
Flux de trésorerie 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.36B | $4.10B | $3.97B | $3.40B | $3.10B | $2.89B | $2.72B | $2.43B | $2.25B | $2.06B | $1.69B | $1.48B | |
| Stock-based Comp | $971M | $1.02B | $1.06B | $925M | $800M | $679M | $697M | $638M | $597M | $485M | $406M | $364M | |
| Deferred Tax | $-1.75B | $-296M | $-245M | $-673M | $130M | $-8M | $230M | $42M | $-965M | $81M | $-73M | $-117M | |
| Amort. of Intangibles | $1.70B | $1.70B | $1.60B | $1.30B | $1.20B | $1.10B | $1.00B | $898M | $896M | $882M | $650M | $524M | |
| Operating Cash Flow | $19.70B | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B | $18.46B | $15.71B | $13.60B | $9.79B | $9.74B | $8.05B | |
| CapEx | $3.62B | $3.50B | $3.39B | $2.80B | $2.45B | $2.05B | $2.07B | $2.06B | $2.02B | $1.71B | $1.56B | $1.52B | |
| Investing Cash Flow | $-8.69B | $-20.53B | $-15.57B | $-28.48B | $-10.37B | $-12.53B | $-12.70B | $-12.38B | $-8.60B | $-9.36B | $-18.39B | $-2.53B | |
| Debt Issued | $2.97B | $17.81B | $6.39B | $14.82B | $6.93B | $4.86B | $5.44B | $6.93B | $5.29B | $3.97B | $11.98B | $2.00B | |
| Net Debt Issued | $-81M | $14.81B | $4.27B | $11.80B | $3.78B | $1.71B | $3.69B | $4.33B | $893M | $1.37B | $10.94B | $1.19B | |
| Stock Issued | $827M | $1.85B | $1.35B | $1.25B | $1.35B | $1.44B | $1.04B | $838M | $688M | $429M | $402M | $462M | |
| Stock Repurchased | $5.54B | $9.00B | $8.00B | $7.00B | $5.00B | $4.25B | $5.50B | $4.50B | $1.50B | $1.28B | $1.20B | $4.01B | |
| Net Stock Activity | $-4.72B | $-7.15B | $-6.65B | $-5.75B | $-3.65B | $-2.81B | $-4.46B | $-3.66B | $-812M | $-851M | $-798M | $-3.55B | |
| Dividends Paid | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B | |
| Financing Cash Flow | $-11.64B | $-3.51B | $-11.53B | $4.23B | $-7.46B | $-3.59B | $-5.62B | $-4.37B | $-3.44B | $-1.01B | $12.24B | $-5.29B | |
| Net Change in Cash | $-947M | $-115M | $2.06B | $1.99B | $4.45B | $5.94B | $119M | $-1.11B | $1.55B | $-493M | $3.43B | $219M | |
| Taxes Paid | $3.71B | $4.62B | $6.08B | $5.22B | $3.97B | $4.93B | $3.54B | $3.26B | $4.00B | $4.73B | $4.40B | $4.02B | |
| Free Cash Flow | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B | $16.39B | $13.65B | $11.57B | $8.09B | $8.18B | $6.53B | |
| Levered FCF | $12.59B | $17.74B | $23.10B | $21.76B | $18.57B | $18.86B | $15.04B | $12.56B | $10.66B | $7.45B | $7.73B | $6.17B |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| Net Margin | 2.7% | 3.6% | 6.0% | 6.2% | 6.0% | 6.0% | 5.7% | 5.3% | 5.2% | 3.8% | 3.7% | 4.3% | |
| Pretax Margin | 3.3% | 5.0% | 7.8% | 8.1% | 7.8% | 8.1% | 7.4% | 7.0% | 7.0% | 6.4% | 6.5% | 7.4% | |
| EBITDA Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| ROA | 4.0% | 4.8% | 8.6% | 8.8% | 8.4% | 8.3% | 8.5% | 8.2% | 8.1% | 6.0% | 5.9% | 6.7% | |
| ROE | 12.0% | 14.5% | 24.3% | 25.2% | 23.3% | 22.6% | 23.4% | 22.4% | 21.7% | 18.5% | 17.4% | 17.3% | |
| ROIC | 9.6% | 14.4% | 16.9% | 16.4% | 15.7% | 15.2% | 15.4% | 14.8% | 14.4% | 10.8% | 9.6% | 12.0% |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | |
| Quick Ratio | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.6 | 0.9 | 1.0 | 0.5 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.5 | |
| Interest Coverage | 4.7 | 8.3 | 10.0 | 13.6 | 14.4 | 13.5 | 11.6 | 12.4 | 12.8 | 12.1 | 14.0 | 16.6 |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.5 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.6 | 1.5 | 1.6 | 1.6 | 1.6 | |
| Inventory Turnover | 14.3 | 14.1 | 12.3 | 10.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 19.7 | 18.3 | 19.1 | 20.3 | 21.2 | 20.8 | 20.9 | 21.6 | 22.7 | 25.2 | 29.2 | 35.7 |
Taux de croissance 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 7.7% | 14.6% | 12.7% | 11.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.3% | 11.7% | 13.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -14.7% | -35.0% | 12.7% | 17.2% | 12.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -14.5% | -5.0% | 14.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -16.3% | -35.6% | 11.2% | 16.4% | 12.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.7% | -5.9% | 13.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -4.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 11.6% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Net Income TTM | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| Market Cap | $299.08B | $462.86B | $486.46B | $495.19B | $472.51B | $331.74B | $278.69B | $239.16B | $213.63B | $152.36B | $112.11B | $96.44B | |
| Enterprise Value | $343.28B | $506.11B | $515.09B | $521.79B | $494.61B | $355.43B | $305.13B | $261.39B | $229.83B | $172.05B | $131.29B | $104.61B | |
| P/E | 25.0 | 32.6 | 22.1 | 25.0 | 27.8 | 21.9 | 20.5 | 20.4 | 20.6 | 22.1 | 19.6 | 17.7 | |
| P/S | 0.7 | 1.2 | 1.3 | 1.5 | 1.6 | 1.3 | 1.2 | 1.1 | 1.1 | 0.8 | 0.7 | 0.7 | |
| P/B | 3.0 | 4.7 | 5.2 | 6.1 | 6.3 | 4.9 | 4.6 | 4.4 | 4.3 | 4.0 | 3.3 | 3.0 | |
| P / Cash Flow | 15.2 | 19.1 | 16.7 | 18.9 | 21.1 | 15.0 | 15.1 | 15.2 | 15.7 | 15.6 | 11.5 | 12.0 | |
| P / FCF | 18.6 | 22.4 | 18.9 | 21.2 | 23.8 | 16.5 | 17.0 | 17.5 | 18.5 | 18.8 | 13.7 | 14.8 | |
| EV / EBITDA | 18.1 | 15.7 | 15.9 | 18.4 | 20.6 | 15.9 | 15.5 | 15.1 | 15.1 | 13.3 | 11.9 | 10.2 | |
| EV / FCF | 21.4 | 24.4 | 20.1 | 22.3 | 24.9 | 17.7 | 18.6 | 19.1 | 19.9 | 21.3 | 16.0 | 16.0 | |
| EV / Revenue | 0.8 | 1.3 | 1.4 | 1.6 | 1.7 | 1.4 | 1.3 | 1.2 | 1.1 | 0.9 | 0.8 | 0.8 | |
| Dividend Yield | 2.6% | 1.6% | 1.4% | 1.2% | 1.1% | 1.4% | 1.4% | 1.4% | 1.3% | 1.5% | 1.6% | 1.4% | |
| Earnings Yield | 4.0% | 3.1% | 4.5% | 4.0% | 3.6% | 4.6% | 4.9% | 4.9% | 4.9% | 4.5% | 5.1% | 5.6% | |
| Payout Ratio | 65.7% | 52.3% | 30.2% | 29.8% | 30.6% | 29.8% | 28.4% | 27.7% | 26.3% | 32.2% | 30.7% | 24.2% | |
| Annual Payout | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B |
Compte de résultat 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $112.03B | $111.72B | $113.22B | $113.16B | $111.62B | $109.58B | $100.81B | $100.82B | $98.86B | $99.80B | $94.43B | $92.36B | $92.90B | $91.93B | $82.79B | $80.89B | |
| Cost of Revenue | $13.38B | $12.82B | $12.68B | $12.57B | $13.02B | $12.39B | $12.46B | $11.83B | $11.34B | $11.06B | $10.19B | $9.42B | $9.75B | $9.40B | $8.31B | $8.31B | |
| SG&A Expense | $14.27B | $15.39B | $17.00B | $15.22B | $13.78B | $13.59B | $12.49B | $13.28B | $13.16B | $14.08B | $13.34B | $13.86B | $13.81B | $13.62B | $13.01B | $11.66B | |
| Operating Expenses | $104.04B | $102.73B | $112.83B | $108.85B | $106.47B | $100.46B | $93.03B | $92.11B | $90.98B | $91.86B | $86.74B | $83.83B | $84.85B | $83.84B | $75.90B | $73.43B | |
| Operating Income | $7.99B | $8.99B | $380M | $4.32B | $5.15B | $9.12B | $7.77B | $8.71B | $7.88B | $7.93B | $7.69B | $8.53B | $8.06B | $8.09B | $6.89B | $7.46B | |
| Interest Expense | $962M | $955M | $974M | $1.00B | $1.03B | $998M | $1.00B | $1.07B | $985M | $844M | $830M | $834M | $828M | $754M | $676M | $516M | |
| Pretax Income | $6.97B | $7.96B | $-720M | $3.23B | $4.08B | $8.11B | $6.79B | $7.61B | $5.67B | $1M | $6.86B | $7.69B | $7.23B | $7.33B | $6.21B | $6.95B | |
| Income Tax | $1.30B | $1.48B | $-938M | $686M | $510M | $1.63B | $1.01B | $1.36B | $1.24B | $1.22B | $1.18B | $1.65B | $1.57B | $1.56B | $1.31B | $1.56B | |
| Net Income | $5.48B | $6.28B | $10M | $2.35B | $3.41B | $6.29B | $5.54B | $6.05B | $4.22B | $-1.41B | $5.46B | $5.84B | $5.47B | $5.61B | $4.76B | $5.26B | |
| EPS (Basic) | $6.06 | $6.92 | $0.03 | $2.59 | $3.76 | $6.90 | $6.03 | $6.56 | $4.58 | $-1.53 | $5.91 | $6.31 | $5.89 | $6.01 | $5.09 | $5.63 | |
| EPS (Diluted) | $6.04 | $6.90 | $0.05 | $2.59 | $3.74 | $6.85 | $5.99 | $6.51 | $4.54 | $-1.53 | $5.85 | $6.24 | $5.82 | $5.95 | $5.02 | $5.55 | |
| Shares (Basic) | 902,000,000 | 908,000,000 | -1,817,000,000 | 906,000,000 | 907,000,000 | 912,000,000 | -1,845,000,000 | 923,000,000 | 921,000,000 | 922,000,000 | -1,861,000,000 | 926,000,000 | 930,000,000 | 933,000,000 | -1,876,000,000 | 935,000,000 | |
| Shares (Diluted) | 906,000,000 | 910,000,000 | -1,825,000,000 | 908,000,000 | 910,000,000 | 918,000,000 | -1,851,000,000 | 930,000,000 | 928,000,000 | 922,000,000 | -1,881,000,000 | 936,000,000 | 940,000,000 | 943,000,000 | -1,902,000,000 | 948,000,000 | |
| EBITDA | $7.99B | $8.99B | · | $4.32B | $5.15B | $9.12B | · | $8.71B | $7.88B | $7.93B | · | $8.53B | $8.06B | $8.09B | · | $7.46B |
Bilan 26
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28.59B | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | $25.31B | $32.40B | $26.29B | $28.41B | · | $38.91B | $41.81B | $41.91B | · | $38.84B | |
| Short-term Investments | $2.88B | $3.23B | $3.76B | $3.40B | $3.42B | $3.57B | $3.80B | $4.73B | $5.04B | $4.30B | · | $5.18B | $4.47B | $4.58B | · | $3.68B | |
| Receivables | $21.57B | $26.59B | $23.02B | $22.67B | $24.14B | $26.94B | $22.36B | $20.02B | $23.11B | $27.20B | · | $20.67B | $17.95B | $22.41B | · | $17.05B | |
| Inventory | · | · | $3.30B | · | · | · | $3.80B | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.10B | $8.72B | $9.75B | $9.02B | $8.96B | $9.04B | $8.21B | $7.64B | $7.42B | $6.13B | · | $5.77B | $5.88B | $6.45B | · | $5.66B | |
| Current Assets | $86.86B | $91.13B | $90.58B | $95.07B | $93.70B | $96.28B | $85.78B | $92.26B | $92.04B | $88.94B | · | $91.91B | $89.87B | $93.89B | · | $82.94B | |
| PP&E (Net) | $10.76B | $10.67B | $10.76B | $11.10B | $10.92B | $10.73B | $10.55B | $10.14B | $9.80B | $10.43B | · | $11.07B | $10.93B | $10.64B | · | $9.47B | |
| Accum. Depreciation | · | · | $7.55B | · | · | · | $6.97B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $110.64B | $110.51B | $110.50B | $110.34B | $107.68B | $107.57B | $106.73B | $105.98B | $105.44B | $105.66B | $103.73B | $101.70B | $101.67B | $100.41B | $93.35B | $83.90B | |
| Intangibles | $19.75B | $20.09B | $20.47B | $22.79B | $22.51B | $22.95B | $23.27B | $23.59B | $14.73B | $15.54B | · | $15.20B | $15.64B | $16.16B | · | $10.79B | |
| Other Non-current Assets | $24.00B | $23.46B | $23.01B | $22.98B | $21.30B | $20.39B | $19.59B | $18.65B | $17.94B | $17.70B | · | $16.71B | $16.07B | $15.69B | · | $14.41B | |
| Total Assets | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | $273.72B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | |
| Accounts Payable | $39.74B | $38.63B | $38.03B | $36.03B | $34.33B | $33.57B | $34.34B | $33.08B | $30.89B | $30.74B | · | $31.16B | $29.52B | $29.86B | · | $27.23B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $7.30B | · | $2.60B | $4.40B | $8.20B | · | · | |
| Current Liabilities | $111.82B | $114.12B | $114.90B | $115.53B | $110.78B | $113.47B | $103.77B | $101.56B | $104.67B | $104.43B | · | $114.18B | $112.98B | $116.48B | · | $100.94B | |
| Deferred Tax | $2.72B | $2.86B | $2.42B | $3.16B | $3.80B | $3.90B | $3.62B | $4.01B | $3.63B | $4.17B | · | $2.21B | $2.50B | $2.83B | · | $1.66B | |
| Other Non-current Liabilities | $19.73B | $18.90B | $18.25B | $18.37B | $15.71B | $15.96B | $15.94B | $15.17B | $14.79B | $14.84B | · | $13.62B | $13.26B | $13.08B | · | $12.11B | |
| Total Liabilities | $203.78B | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B | $195.69B | $194.85B | $186.82B | $187.29B | · | $188.08B | $188.01B | $193.06B | · | $160.14B | |
| Total Debt | $69.50B | $71.44B | · | $72.40B | $73.50B | $71.28B | · | $74.10B | $63.73B | $71.15B | · | $60.68B | $63.67B | $68.86B | · | $45.44B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $10M | |
| Paid-in Capital | $0 | $556M | $559M | $394M | · | · | $0 | $461M | $373M | · | · | · | · | · | · | · | |
| Retained Earnings | $100.96B | $99.88B | $95.60B | $97.59B | $97.25B | $97.93B | $96.04B | $96.52B | $92.40B | $90.12B | · | $93.17B | $89.99B | $88.85B | · | $83.72B | |
| AOCI | $-2.52B | $-2.56B | $-2.06B | $-2.21B | $-2.54B | $-2.90B | $-3.39B | $-2.45B | $-3.42B | $-3.44B | · | $-8.69B | $-7.65B | $-7.55B | · | $-9.09B | |
| Stockholders' Equity | $104.51B | $103.89B | $100.09B | $101.57B | $100.47B | $100.81B | $98.27B | $99.88B | $94.68B | $92.37B | $94.42B | $89.56B | $87.37B | $85.82B | $81.45B | $78.06B | |
| Liabilities + Equity | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | · | $282.06B | $280.16B | $283.68B | · | $243.06B | |
| Shares Outstanding | 905,000,000 | 908,000,000 | 906,000,000 | 906,000,000 | 905,000,000 | 910,000,000 | 915,000,000 | 923,000,000 | 921,000,000 | 920,000,000 | 924,000,000 | 925,000,000 | 927,000,000 | 932,000,000 | 934,000,000 | 935,000,000 |
Flux de trésorerie 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.04B | $1.03B | $1.12B | $1.10B | $1.08B | $1.06B | $1.04B | $1.04B | $1.02B | $997M | $974M | $1.01B | $1.02B | $970M | $982M | $828M | |
| Stock-based Comp | $276M | $348M | $176M | $223M | $197M | $375M | $187M | $237M | $222M | $372M | $208M | $247M | $242M | $362M | $250M | $171M | |
| Deferred Tax | $-129M | $540M | $-733M | $-932M | $-151M | $64M | $-62M | $124M | $-331M | $-27M | $249M | $-12M | $-150M | $-332M | $-83M | $-575M | |
| Operating Cash Flow | $11.05B | $8.91B | $1.11B | $5.95B | $7.19B | $5.46B | $2.37B | $13.95B | $6.75B | $1.14B | $-5.19B | $6.90B | $11.03B | $16.33B | $-4.53B | $18.55B | |
| CapEx | $799M | $763M | $948M | $890M | $886M | $898M | $912M | $991M | $853M | $743M | $959M | $838M | $829M | $760M | $866M | $724M | |
| Investing Cash Flow | $-1.80B | $-2.45B | $-2.61B | $-4.56B | $-1.44B | $-74M | $-1.12B | $-5.65B | $-7.42B | $-6.34B | $-1.19B | $-2.64B | $-728M | $-11.02B | $-15.37B | $-847M | |
| Debt Issued | · | · | $0 | $0 | $2.97B | $0 | $0 | $11.89B | $0 | $5.92B | $0 | $0 | $-7M | $6.40B | $8.90B | $0 | |
| Net Debt Issued | · | $-1.50B | · | · | · | $0 | · | · | · | $5.17B | · | · | · | $5.03B | · | · | |
| Stock Issued | $128M | $231M | $24M | $222M | $221M | $360M | $235M | $867M | $258M | $486M | $314M | $411M | $284M | $344M | $169M | $328M | |
| Stock Repurchased | $1.65B | $0 | $0 | $0 | $2.54B | $3.00B | $4.97B | $956M | $0 | $3.07B | $1.50B | $1.50B | $3.00B | $2.00B | $1.00B | $1.00B | |
| Net Stock Activity | · | $231M | · | · | · | $-2.64B | · | · | · | $-2.59B | · | · | · | $-1.66B | · | · | |
| Dividends Paid | $2.09B | $2.00B | $2.00B | $2.00B | $2.00B | $1.91B | $1.93B | $1.94B | $1.94B | $1.73B | $1.74B | $1.74B | $1.75B | $1.54B | $1.54B | $1.54B | |
| Financing Cash Flow | $-8.62B | $-2.99B | $-1.03B | $-2.77B | $-7.95B | $99M | $-8.34B | $-2.21B | $-1.20B | $8.23B | $-7.16B | $-7.10B | $-10.46B | $13.19B | $4.39B | $-3.42B | |
| Net Change in Cash | $584M | $3.64B | $-2.85B | $-1.39B | $-2.12B | $5.41B | $-7.09B | $6.11B | $-2.13B | $2.99B | $-13.49B | $-2.90B | $-100M | $18.55B | $-15.48B | $14.23B | |
| Free Cash Flow | · | $8.15B | · | · | · | $4.56B | · | · | · | $401M | · | · | · | $15.57B | · | · | |
| Levered FCF | · | $7.37B | · | · | · | $3.76B | · | · | · | $1.03T | · | · | · | $14.97B | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 7.1% | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | |
| Net Margin | 4.9% | 5.6% | · | 2.1% | 3.0% | 5.7% | · | 6.0% | 4.3% | -1.4% | · | 6.3% | 5.9% | 6.1% | · | 6.5% | |
| Pretax Margin | 6.2% | 7.1% | · | 2.9% | 3.7% | 7.4% | · | 7.5% | 5.7% | 0.00% | · | 8.3% | 7.8% | 8.0% | · | 8.6% | |
| EBITDA Margin | 7.1% | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | |
| ROA | 1.8% | 2.0% | · | 0.76% | 1.1% | 2.1% | · | 2.1% | 1.5% | -0.50% | · | 2.2% | 2.1% | 2.2% | · | 2.3% | |
| ROE | 5.3% | 6.1% | · | 2.3% | 3.5% | 6.5% | · | 6.4% | 4.6% | -1.6% | · | 7.0% | 6.7% | 6.9% | · | 7.0% | |
| ROIC | 3.7% | 4.2% | · | 1.9% | 2.6% | 4.2% | · | 4.1% | 3.9% | -5922.1% | · | 4.5% | 4.2% | 4.1% | · | 4.7% |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | |
| Interest Coverage | 8.3 | 9.4 | · | 4.3 | 5.0 | 9.1 | · | 8.1 | 8.0 | 9.4 | · | 10.2 | 9.7 | 10.7 | · | 14.5 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 4.9 | 4.2 | · | 5.3 | 4.7 | 4.0 | · | 5.0 | 4.8 | 4.0 | · | 4.9 | 5.1 | 4.5 | · | 5.2 |
Valorisation (TTM) 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $448.53B | $446.07B | · | $435.17B | $420.87B | $409.05B | · | $391.83B | $383.92B | $376.99B | · | $358.09B | $346.06B | $333.31B | · | $313.71B | |
| Net Income TTM | $17.52B | $18.33B | · | $18.10B | $19.97B | $15.15B | · | $14.70B | $14.12B | $15.52B | · | $22.19B | $21.42B | $20.97B | · | $19.45B | |
| Market Cap | $376.15B | $245.70B | · | $312.84B | $282.33B | $476.61B | · | $539.66B | $469.03B | $455.12B | · | $466.38B | $445.55B | $440.45B | · | $472.21B | |
| Enterprise Value | $414.18B | $285.91B | · | $354.63B | $323.81B | $513.61B | · | $576.63B | $501.43B | $493.56B | · | $482.96B | $462.94B | $462.81B | · | $475.12B | |
| P/E | 21.6 | 13.5 | · | 17.5 | 14.4 | 32.0 | · | 37.1 | 33.8 | 30.0 | · | 21.4 | 21.2 | 21.4 | · | 24.7 | |
| P/S | 0.8 | 0.6 | · | 0.7 | 0.7 | 1.2 | · | 1.4 | 1.2 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.5 | |
| P/B | 3.6 | 2.4 | · | 3.1 | 2.8 | 4.7 | · | 5.4 | 5.0 | 4.9 | · | 5.2 | 5.1 | 5.1 | · | 6.0 | |
| P / Cash Flow | · | 27.6 | · | · | · | 87.4 | · | · | · | 397.8 | · | · | · | 27.0 | · | · | |
| P / FCF | · | 30.2 | · | · | · | 104.6 | · | · | · | 1135.0 | · | · | · | 28.3 | · | · | |
| EV / EBITDA | 51.8 | 31.8 | · | 82.2 | 62.9 | 56.3 | · | 66.2 | 63.7 | 62.2 | · | 56.6 | 57.5 | 57.2 | · | 63.7 | |
| EV / FCF | · | 35.1 | · | · | · | 112.7 | · | · | · | 1230.8 | · | · | · | 29.7 | · | · | |
| EV / Revenue | 0.9 | 0.6 | · | 0.8 | 0.8 | 1.3 | · | 1.5 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.4 | · | 1.5 | |
| Earnings Yield | 4.6% | 7.4% | · | 5.7% | 6.9% | 3.1% | · | 2.7% | 3.0% | 3.3% | · | 4.7% | 4.7% | 4.7% | · | 4.0% | |
| Payout Ratio | · | 31.9% | · | · | · | 30.4% | · | · | · | -122.7% | · | · | · | 27.4% | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Revenu | $447.57B | — | — | $400.28B | — |
| Marge d'exploitation % | 4.2% | — | — | 8.1% | — |
| Résultat net | $12.06B | — | — | $14.40B | — |
| BPA dilué | $13.23 | — | — | $15.51 | — |
Bilan
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.7 | — | — | 0.7 | — |
| Ratio de liquidité | 0.8 | — | — | 0.8 | — |
| Ratio de liquidité réduite | 0.4 | — | — | 0.5 | — |
Flux de trésorerie
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $16.07B | — | — | $20.70B | — |
Dernières actualités Actualités récentes mentionnant cette entreprise
- L'action United Health est-elle toujours sous-évaluée ?
- UnitedHealth Lost Nearly 1 Million Medicare Members. Here's Why Investors Aren't Worried
- UnitedHealth Group boosts earnings outlook after stronger-than-expected Q2 results
- UnitedHealth Group : faut-il acheter après ses derniers résultats ?
- JPMorgan Raises its Price Target on UnitedHealth Group (UNH)
- UnitedHealth Stock Jumps on Upgrade From Bank of America. UNH Is No Longer Just an Insurance Company.
- Rapport quotidien sur les dividendes : MDT, ACM, UNH, RICK, VRT
- Ce géant de la santé devient discrètement une puissance de l'IA
- UnitedHealth Group (UNH) – Parmi les 10 actions de haute qualité à acheter selon les Hedge Funds
- Les actions de UnitedHealth (UNH) baissent suite à la sortie de Berkshire Hathaway, rapporte Reuters
Signaux de trading Signaux d'achat/vente récents avec prix d'entrée et ratio risque/récompense
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 3 750 déclarants · $243.6B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 507 (+257 vs T. préc.) | 124 (-254 vs T. préc.) | 1 283 (+66 vs T. préc.) | 1 289 (-96 vs T. préc.) | +25.6M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $27 207 979 474 | 82 420 949 | 11,17% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $24 651 649 136 | 59 311 525 | 10,12% | Actions |
| STATE STREET CORP | $18 966 554 763 | 45 633 267 | 7,79% | Actions |
| Capital World Investors | $12 422 776 956 | 29 887 932 | 5,10% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10 175 966 547 | 24 483 234 | 4,18% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $7 770 611 877 | 18 774 463 | 3,19% | Actions |
| FMR LLC | $7 185 101 298 | 17 287 254 | 2,95% | Actions |
| NORGES BANK | $5 293 868 088 | 12 736 973 | 2,17% | Actions |
| Capital Research Global Investors | $4 378 631 657 | 10 534 177 | 1,80% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $4 210 086 678 | 10 129 410 | 1,73% | Actions |
| Fisher Asset Management, LLC | $3 774 863 715 | 9 082 269 | 1,55% | Actions |
| Dodge & Cox | $3 770 702 593 | 9 072 258 | 1,55% | Actions |
| Capital International Investors | $3 237 872 783 | 7 789 028 | 1,33% | Actions |
| JANE STREET GROUP, LLC | $3 165 978 399 | 7 617 300 | 1,30% | Option d'achat |
| Sanders Capital, LLC | $2 451 649 249 | 5 898 634 | 1,01% | Actions |
| EAGLE CAPITAL MANAGEMENT LLC | $2 399 442 912 | 5 773 026 | 0,99% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $2 119 167 278 | 5 098 687 | 0,87% | Actions |
| ALLIANCEBERNSTEIN L.P. | $2 075 268 358 | 7 669 420 | 0,85% | Actions |
| MORGAN STANLEY | $2 055 731 816 | 4 946 062 | 0,84% | Actions |
| JANE STREET GROUP, LLC | $2 055 124 098 | 4 944 600 | 0,84% | Option de vente |
| DIMENSIONAL FUND ADVISORS LP | $1 717 292 161 | 4 131 778 | 0,71% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $1 526 781 892 | 3 673 416 | 0,63% | Actions |
| AMERIPRISE FINANCIAL INC | $1 405 176 851 | 3 380 319 | 0,58% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1 251 138 985 | 3 010 223 | 0,51% | Actions |
| Grantham, Mayo, Van Otterloo & Co. LLC | $1 174 164 878 | 2 825 022 | 0,48% | Actions |
| BlackRock, Inc. | $1 158 005 862 | 2 786 146 | 0,48% | Actions |
| UBS Group AG | $1 092 471 817 | 2 628 472 | 0,45% | Option d'achat |
| BANK OF AMERICA CORP /DE/ | $1 087 853 337 | 2 617 360 | 0,45% | Actions |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1 065 664 884 | 2 563 973 | 0,44% | Actions |
| Swiss National Bank | $1 064 029 841 | 2 560 041 | 0,44% | Actions |
| Sumitomo Mitsui Trust Group, Inc. | $1 055 107 927 | 2 538 575 | 0,43% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $971 757 071 | 2 338 034 | 0,40% | Actions |
| BARCLAYS PLC | $897 842 266 | 2 160 196 | 0,37% | Actions |
| RAYMOND JAMES FINANCIAL INC | $874 984 816 | 2 105 201 | 0,36% | Actions |
| Walleye Trading LLC | $861 060 671 | 2 071 700 | 0,35% | Option de vente |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $860 919 095 | 2 071 359 | 0,35% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $847 773 811 | 2 039 732 | 0,35% | Actions |
| Walleye Trading LLC | $845 183 605 | 2 033 500 | 0,35% | Option d'achat |
| Vanguard Global Advisers, LLC | $819 257 021 | 1 971 121 | 0,34% | Actions |
| National Pension Service | $818 929 089 | 1 970 332 | 0,34% | Actions |
| WOLVERINE TRADING, LLC | $815 453 232 | 2 362 400 | 0,33% | Option d'achat |
| ENVESTNET ASSET MANAGEMENT INC | $811 129 699 | 1 951 573 | 0,33% | Actions |
| California Public Employees Retirement System | $799 750 674 | 1 924 189 | 0,33% | Actions |
| Pentwater Capital Management LP | $777 228 100 | 1 870 000 | 0,32% | Option d'achat |
| Legal & General Group Plc | $771 950 431 | 1 857 302 | 0,32% | Actions |
| HSBC HOLDINGS PLC | $751 372 125 | 1 802 500 | 0,31% | Option de vente |
| MILLENNIUM MANAGEMENT LLC | $672 345 116 | 1 617 653 | 0,28% | Actions |
| GOLDMAN SACHS GROUP INC | $636 389 783 | 1 531 145 | 0,26% | Actions |
| MARSHFIELD ASSOCIATES | $634 316 697 | 1 526 157 | 0,26% | Actions |
| UBS Group AG | $621 815 730 | 1 496 080 | 0,26% | Actions |
| RHUMBLINE ADVISERS | $607 608 189 | 1 461 895 | 0,25% | Actions |
| Ensign Peak Advisors, Inc | $599 888 338 | 1 443 323 | 0,25% | Actions |
| Qube Research & Technologies Ltd | $584 349 595 | 1 405 937 | 0,24% | Actions |
| Caisse de depot et placement du Quebec | $566 755 977 | 1 363 607 | 0,23% | Actions |
| AMERICAN CENTURY COMPANIES INC | $566 576 841 | 1 363 176 | 0,23% | Actions |
| Assenagon Asset Management S.A. | $542 834 808 | 1 306 053 | 0,22% | Actions |
| 1832 Asset Management L.P. | $537 572 517 | 1 293 392 | 0,22% | Actions |
| LPL Financial LLC | $531 650 741 | 1 279 144 | 0,22% | Actions |
| Davis Selected Advisers | $529 839 298 | 1 274 650 | 0,22% | Actions |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $528 071 215 | 1 270 532 | 0,22% | Actions |
| WOLVERINE TRADING, LLC | $512 799 408 | 1 485 600 | 0,21% | Option de vente |
| HSBC HOLDINGS PLC | $508 842 509 | 1 224 268 | 0,21% | Actions |
| FIL Ltd | $462 416 638 | 1 112 568 | 0,19% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $461 418 710 | 1 110 167 | 0,19% | Actions |
| Ninety One UK Ltd | $458 593 637 | 1 103 370 | 0,19% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $456 902 059 | 1 099 300 | 0,19% | Option d'achat |
| Nuveen Asset Management, LLC | $449 500 757 | 888 587 | 0,18% | Actions |
| Veritas Asset Management LLP | $448 132 682 | 1 078 201 | 0,18% | Actions |
| NAYA CAPITAL MANAGEMENT UK LTD | $436 832 118 | 1 051 012 | 0,18% | Actions |
| NEUBERGER BERMAN GROUP LLC | $435 590 401 | 1 047 589 | 0,18% | Actions |
| MACKENZIE FINANCIAL CORP | $431 689 943 | 1 038 640 | 0,18% | Actions |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $430 280 958 | 1 035 250 | 0,18% | Actions |
| CTC LLC | $424 566 045 | 10 215 | 0,17% | Option de vente |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $411 538 954 | 990 157 | 0,17% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $408 705 604 | 983 340 | 0,17% | Actions |
| JANE STREET GROUP, LLC | $402 713 051 | 968 922 | 0,17% | Actions |
| CITADEL ADVISORS LLC | $400 319 438 | 963 163 | 0,16% | Actions |
| CTC LLC | $395 596 634 | 9 518 | 0,16% | Option d'achat |
| Fayez Sarofim & Co | $394 573 729 | 949 339 | 0,16% | Actions |
| D. E. Shaw & Co., Inc. | $382 462 726 | 920 200 | 0,16% | Option de vente |
| GOLDMAN SACHS GROUP INC | $375 355 453 | 903 100 | 0,15% | Option de vente |
| MILLENNIUM MANAGEMENT LLC | $372 529 169 | 896 300 | 0,15% | Option de vente |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $366 901 369 | 1 355 931 | 0,15% | Actions |
| Allen Investment Management, LLC | $364 199 528 | 876 259 | 0,15% | Actions |
| FIRST MANHATTAN CO. LLC. | $360 530 629 | 867 432 | 0,15% | Actions |
| PRUDENTIAL FINANCIAL INC | $359 505 403 | 864 965 | 0,15% | Actions |
| Longview Partners (Guernsey) LTD | $350 167 028 | 842 497 | 0,14% | Actions |
| W1M Asset Management Ltd | $349 962 345 | 842 562 | 0,14% | Actions |
| AVIVA PLC | $347 327 444 | 835 665 | 0,14% | Actions |
| Point72 Asset Management, L.P. | $345 328 264 | 830 855 | 0,14% | Actions |
| TD Asset Management Inc | $337 496 548 | 812 012 | 0,14% | Actions |
| TORONTO DOMINION BANK | $337 017 326 | 810 859 | 0,14% | Actions |
| PineStone Asset Management Inc. | $335 630 369 | 807 522 | 0,14% | Actions |
| JENNISON ASSOCIATES LLC | $335 325 296 | 806 788 | 0,14% | Actions |
| PeakShares LLC | $329 595 000 | 793 | 0,14% | Actions |
| US BANCORP \DE\ | $328 365 156 | 790 042 | 0,13% | Actions |
| JONES FINANCIAL COMPANIES LLLP | $325 830 242 | 761 481 | 0,13% | Actions |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $320 418 726 | 770 923 | 0,13% | Actions |
| Clearbridge Investments, LLC | $312 811 372 | 752 620 | 0,13% | Actions |
| Robeco Institutional Asset Management B.V. | $311 375 867 | 749 166 | 0,13% | Actions |
Initiés de la société 64 initiés · 37 dirigeants · 27 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Timothy John Noel | Chief Executive Officer, UHC | 23 juin 2026 A | 17 651 | 0 | 0 | $0 |
| Stephen J Hemsley | CEO, UHG | 23 juin 2026 A | 48 099 | 0 | 0 | $0 |
| Heather Cianfrocco | Chief Executive Officer, Optum | 18 mars 2025 A | 22 438 | 0 | 0 | $0 |
| Andrew Witty | CEO, UHG | 18 mars 2025 A | 112 162 | 0 | 0 | $0 |
| Brian R Thompson | CEO, UnitedHealthcare | 24 septembre 2024 A | 32 675 | 0 | 0 | $0 |
| David S Wichmann | Chief Executive Officer | 16 décembre 2020 F | 967 872 | 0 | 0 | $0 |
| Steven H Nelson | EVP & CEO, UnitedHealthcare | 25 juin 2019 A | 38 502 | 0 | 0 | $0 |
| Larry C Renfro | Vice Chmn, UHG and CEO, Optum | 26 juin 2018 A | 153 790 | 0 | 0 | $0 |
| Gail Boudreaux | EVP & CEO, UnitedHealthcare | 23 septembre 2014 A | 184 732 | 0 | 0 | $0 |
| George Lawrence Mikan III | EVP UHG & CEO, Optum | 5 juin 2011 F | 209 279 | 0 | 0 | $0 |
| Tracy L Bahl | CEO, Uniprise | 7 novembre 2006 A | 4 230 | 0 | 0 | $0 |
| Robert J Sheehy | CEO, UnitedHealthcare | 7 novembre 2006 A | 3 009 | 0 | 0 | $0 |
| MCGUIRE WILLIAM W | Chief Executive Officer | 7 novembre 2006 A | 644 862 | 0 | 0 | $0 |
| Channing R Wheeler | CEO, Uniprise, Inc. | 28 novembre 2003 J | 8 356 | 0 | 0 | $0 |
| Wayne S Deveydt | Chief Financial Officer | 23 juin 2026 A | 19 779 | 0 | 0 | $0 |
| John F Rex | President & CFO | 24 juin 2025 A | 203 898 | 0 | 0 | $0 |
| Patrick J Erlandson | Chief Financial Officer | 2 mai 2006 A | 7 083 | 0 | 0 | $0 |
| Dirk C Mcmahon | President & COO, UHG | 19 mars 2024 A | 70 547 | 0 | 0 | $0 |
| Christopher R Zaetta | EVP & Chief Legal Officer | 23 juin 2026 A | 15 860 | 0 | 0 | $0 |
| Erin Mcsweeney | EVP & Chief People Officer | 23 juin 2026 A | 15 601 | 0 | 0 | $0 |
| Thomas E Roos | Chief Accounting Officer | 23 février 2026 A | 31 284 | 0 | 0 | $0 |
| Rupert M Bondy | EVP & Chief Legal Officer | 19 mars 2024 A | 9 607 | 0 | 0 | $0 |
| Marianne D Short | EVP & Chief Legal Officer | 25 février 2022 F | 138 315 | 0 | 0 | $0 |
| Patricia L Lewis | EVP and Chief HR Officer | 13 février 2022 F | 8 901 | 0 | 0 | $0 |
| Ellen D Wilson | Executive Vice President | 24 mars 2020 A | 58 387 | 0 | 0 | $0 |
| Eric S Rangen | Sr VP & Chief Acctg Officer | 24 juin 2015 A | 11 577 | 0 | 0 | $0 |
| Lori Sweere | EVP, Human Capital | 10 mai 2013 S | 70 661 | 0 | 0 | $0 |
| Richard N Baer | EVP & Chief Legal Officer | 28 décembre 2012 F | 63 880 | 0 | 0 | $0 |
| Reed Vaughn Tuckson | EVP & Chief of Medical Affairs | 5 juin 2012 F | 116 886 | 0 | 0 | $0 |
| William A Munsell | EVP, UnitedHealth Group | 5 juin 2012 F | 268 167 | 0 | 0 | $0 |
| Anthony Welters | EVP, UnitedHealth Group | 5 juin 2012 F | 119 909 | 0 | 0 | $0 |
| Christopher James Walsh | EVP and General Counsel | 24 mai 2011 A | 101 338 | 0 | 0 | $0 |
| Mitchell Eliot Zamoff | EVP and General Counsel | 24 mai 2011 A | 113 613 | 0 | 0 | $0 |
| Thomas L Strickland | EVP & Chief Legal Officer | 5 juin 2008 A | 147 182 | 0 | 0 | $0 |
| Richard H Anderson | EVP, Pres, Commercial Svcs Grp | 28 mai 2007 A | 40 606 | 0 | 0 | $0 |
| Lois E Quam | EVP & Pres, Pub & Sr Mkt Grp | 28 mai 2007 A | 13 915 | 0 | 0 | $0 |
| Forrest Gregory Burke | Acting General Counsel | 17 avril 2007 A | — | 0 | 0 | $0 |
| Frederick William Mcnabb III | Administrateur | 1 juillet 2026 A | 15 462 | 0 | 0 | $0 |
| Kristen Gil | Administrateur | 1 juillet 2026 A | 2 617 | 0 | 0 | $0 |
| Rice Valerie Montgomery MD | Administrateur | 1 juillet 2026 A | 7 876 | 0 | 0 | $0 |
| John H Noseworthy | Administrateur | 1 juillet 2026 A | 7 616 | 0 | 0 | $0 |
| Charles D. Baker | Administrateur | 1 juillet 2026 A | 2 396 | 0 | 1 | $-9 613 |
| Timothy Patrick Flynn | Administrateur | 1 juillet 2026 A | 10 875 | 0 | 0 | $0 |
| Scott Gottlieb | Administrateur | 1 juillet 2026 A | 659 | 0 | 0 | $0 |
| Paul R Garcia | Administrateur | 1 juillet 2026 A | 3 906 | 0 | 0 | $0 |
| Michele J Hooper | Administrateur | 1 avril 2026 A | 41 792 | 0 | 0 | $0 |
| BURKE RICHARD T | Administrateur | 19 mai 2022 S | 1 215 000 | 0 | 0 | $0 |
| Gail R Wilensky | Administrateur | 1 avril 2022 A | 24 690 | 0 | 0 | $0 |
| Glenn M Renwick | Administrateur | 1 avril 2021 A | 85 130 | 0 | 0 | $0 |
| BALLARD WILLIAM C JR | Administrateur | 1 avril 2020 A | 62 266 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 2 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| UnitedHealth Group Incorporated ×3 dépôts | 15 janvier 2021 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
| Ingenix, Inc., UnitedHealth Group Incorporated | 5 juin 2006 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 275 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IHF · iShares Trust | 20,01% | 634 654 SH | 21 août 2026 | Quotidien |
| DJD · Invesco Exchange-Traded Fund Trust | 7,73% | 101 155 SH | 21 août 2026 | Quotidien |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 5,83% | 1 751 NS | 30 avril 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 5,56% | 2 728 542 SH | 19 août 2026 | Quotidien |
| FHLC · FIDELITY COVINGTON TRUST | 5,42% | 417 583 NS | 30 avril 2026 | N-PORT |
| IYH · iShares Trust | 5,37% | 538 654 SH | 21 août 2026 | Quotidien |
| HRTS · Tema ETF Trust | 5,24% | 7 159 NS | 31 mai 2026 | N-PORT |
| FLAG · Global X Funds | 5,12% | 228 NS | 30 avril 2026 | N-PORT |
| SCHD · SCHWAB STRATEGIC TRUST | 5,09% | 12 713 822 NS | 31 mai 2026 | N-PORT |
| RXL · ProShares Trust | 4,98% | 9 446 NS | 31 mai 2026 | N-PORT |
| DOGG · First Trust Exchange-Traded Fund IV | 4,95% | 8 762 NS | 30 avril 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 4,84% | 18 062 NS | 30 avril 2026 | N-PORT |
| DJIA · Global X Funds | 4,63% | 21 113 NS | 30 avril 2026 | N-PORT |
| DYLG · Global X Funds | 4,61% | 732 NS | 30 avril 2026 | N-PORT |
| VEGN · ETF Series Solutions | 4,22% | 17 678 NS | 30 avril 2026 | N-PORT |
| GFGF · EA Series Trust | 3,98% | 3 881 NS | 29 mai 2026 | N-PORT |
| IXJ · iShares Trust | 3,79% | 428 796 SH | 21 août 2026 | Quotidien |
| EQIN · Columbia ETF Trust I | 3,65% | 27 252 NS | 30 avril 2026 | N-PORT |
| LGRO · ALPS ETF Trust | 3,45% | 12 238 NS | 31 mai 2026 | N-PORT |
| JXX · Janus Detroit Street Trust | 3,34% | 3 270 NS | 30 avril 2026 | N-PORT |
| EDOW · First Trust Exchange-Traded Fund | 3,32% | 24 460 NS | 30 juin 2026 | N-PORT |
| DDM · ProShares Trust | 3,30% | 45 359 NS | 31 mai 2026 | N-PORT |
| PRVS · Parnassus Funds II | 3,25% | 1 978 NS | 30 juin 2026 | N-PORT |
| BKDV · BNY Mellon ETF Trust II | 3,14% | 117 081 NS | 30 avril 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 3,10% | 149 362 SH | 21 août 2026 | Quotidien |
| QLTY · GMO ETF Trust | 2,85% | 337 119 NS | 31 mai 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 2,72% | 735 NS | 31 mai 2026 | N-PORT |
| FMCX · Northern Lights Fund Trust IV | 2,67% | 8 276 NS | 31 mai 2026 | N-PORT |
| FMCE · Northern Lights Fund Trust IV | 2,67% | 4 741 NS | 31 mai 2026 | N-PORT |
| CBLS · Elevation Series Trust | 2,65% | 3 800 NS | 30 avril 2026 | N-PORT |
| UDOW · ProShares Trust | 2,52% | 55 671 NS | 31 mai 2026 | N-PORT |
| TBG · EA Series Trust | 2,51% | 15 609 NS | 30 avril 2026 | N-PORT |
| ESN · Northern Lights Fund Trust II | 2,47% | 18 098 NS | 31 mai 2026 | N-PORT |
| OMAH · Tidal Trust III | 2,46% | 49 724 NS | 30 avril 2026 | N-PORT |
| SNPV · DBX ETF Trust | 2,35% | 14 245 NS | 29 mai 2026 | N-PORT |
| PALC · Pacer Funds Trust | 2,35% | 14 601 NS | 30 avril 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 2,25% | 2 424 NS | 31 mai 2026 | N-PORT |
| PY · Principal Exchange-Traded Funds | 2,11% | 11 168 NS | 30 juin 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 2,09% | 539 098 SH | 21 août 2026 | Quotidien |
| SFYF · Tidal Trust I | 2,08% | 2 389 NS | 31 mai 2026 | N-PORT |
| FLV · AMERICAN CENTURY ETF TRUST | 2,07% | 19 236 NS | 31 mai 2026 | N-PORT |
| HGRO · ETF Opportunities Trust | 2,06% | 5 413 NS | 30 avril 2026 | N-PORT |
| CGDV · Capital Group Dividend Value ETF | 2,02% | 1 872 479 NS | 31 mai 2026 | N-PORT |
| GMOV · GMO ETF Trust | 2,02% | 4 839 NS | 31 mai 2026 | N-PORT |
| DUSA · Davis Fundamental ETF Trust | 1,96% | 61 270 NS | 30 avril 2026 | N-PORT |
| GVIP · Goldman Sachs ETF Trust | 1,84% | 27 590 NS | 31 mai 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 1,78% | 570 801 SH | 19 août 2026 | Quotidien |
| MEDI · Harbor ETF Trust | 1,77% | 1 315 NS | 30 avril 2026 | N-PORT |
| CAPE · DoubleLine ETF Trust | 1,72% | 9 864 NS | 30 juin 2026 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 1,65% | 5 130 541 SH | 19 août 2026 | Quotidien |